Notably, the level of IL-21R on the peripheral CD8+ T cells, but not the serum level of IL-21, was associated with bone marrow involvement and B symptoms, indicating that IL-21R on peripheral CD8+ T cells may play more significant roles in the progression of DLBCL. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.